Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

Healthcare Cannabis

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > NDA/ANDA/505

<< Previous

Bullboard Posts

Next >>

Comment by QContinuum1on Jul 02, 2024 3:04pm

43 Views

Post# 36114937

RE:RE:NDA/ANDA/505

Solid1 wrote: The ANDA and NDA filing was first mentioned in the Q3 2022 conference call. But then came the Jazz lawsuit, which presumably delayed everything, and finally the application was officially filed in September 2023. I assume the patent infringement was reviewed in the time in between

ANDA is Epiodiolex, we know that. NDA is not and has not been mentioned.

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages